HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 288/4/E715    most recent 00113.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Erraji-Benchekroun, L. Articles by André, C. Search for Related Content PubMed PubMed Citation Articles by Erraji-Benchekroun, L. Articles by André, C.

Overexpression of ₂-adrenergic receptors in mouse liver alters the expression of gluconeogenic and glycolytic enzymes

Departments of ¹Immunology, ²Genetics, Development and Molecular Pathology, and ³Endocrinology, Institut Cochin, Institut National de la Santé et de la Recherche Médicale U 567/Centre National de la Recherche Scientifique Unité Mixte de Recherche 8104, Paris, France

Submitted 9 March 2004 ; accepted in final form 24 November 2004

In the livers of humans and many other mammalian species, ₂-adrenergic receptors (₂-ARs) play an important role in the modulation of glucose production by glycogenolysis and gluconeogenesis. In male mice and rats, however, the expression and physiological role of hepatic ₂-ARs are rapidly lost with development under normal physiological conditions. We previously described a line of transgenic mice, F28 (André C, Erraji L, Gaston J, Grimber G, Briand P, and Guillet JG. Eur J Biochem 241: 417–424, 1996), which carry the human ₂-AR gene under the control of its own promoter. In these mice, hepatic ₂-AR levels are shown to increase rapidly after birth and, as in humans, be maintained at an elevated level in adulthood. F28 mice display strongly enhanced adenylyl cyclase responses to -AR agonists in their livers and, compared with normal mice, have increased basal hepatic adenylyl cyclase activity. In this report we demonstrate that, under normal physiological conditions, this increased ₂-AR activity affects the expression of the gluconeogenic and glycolytic key enzymes phosphoenolpyruvate carboxykinase, glucose-6-phosphatase, and L-pyruvate kinase and considerably decreases hepatic glycogen levels. Furthermore, we show that the effects of -adrenergic ligands on liver glycogen observed in humans are reproduced in these mice: liver glycogen levels are strongly decreased by the ₂-AR agonist clenbuterol and increased by the -AR antagonist propranolol. These transgenic mice open new perspectives for studying in vivo the hepatic ₂-AR system physiopathology and for testing the effects of -AR ligands on liver metabolism.

-adrenergic receptor; glycogen; glucose; phosphoenolpyruvate carboxykinase; L-pyruvate kinase